For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
In the latest session, Spero Therapeutics Inc (NASDAQ: SPRO) closed at $2.49 up 5.51% from its previous closing price of $2.36. In other words, the price has increased by $5.51 from its previous closing price. On the day, 0.59 million shares were traded. SPRO stock price reached its highest trading level at $2.49 during the session, while it also had its lowest trading level at $2.36.
Ratios:
For a deeper understanding of Spero Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.97 and its Current Ratio is at 3.97. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.05.
On September 23, 2022, Evercore ISI Upgraded its rating to Outperform which previously was In-line and also upped its target price recommendation from $2 to $8.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 28 ’25 when Mahadevia Ankit sold 6,572 shares for $1.97 per share. The transaction valued at 12,947 led to the insider holds 703,294 shares of the business.
Keutzer Timothy sold 1,695 shares of SPRO for $3,339 on Aug 28 ’25. The Chief Operating Officer now owns 739,744 shares after completing the transaction at $1.97 per share. On Feb 05 ’25, another insider, Keutzer Timothy, who serves as the Chief Operating Officer of the company, sold 56,537 shares for $0.78 each. As a result, the insider received 44,099 and left with 741,439 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SPRO now has a Market Capitalization of 140125312 and an Enterprise Value of 112546312. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.11 while its Price-to-Book (P/B) ratio in mrq is 4.26. Its current Enterprise Value per Revenue stands at 2.317 whereas that against EBITDA is -1.997.
Stock Price History:
The Beta on a monthly basis for SPRO is 1.49, which has changed by 0.83657587 over the last 52 weeks, in comparison to a change of 0.14201736 over the same period for the S&P500. Over the past 52 weeks, SPRO has reached a high of $3.22, while it has fallen to a 52-week low of $0.51. The 50-Day Moving Average of the stock is 22.21%, while the 200-Day Moving Average is calculated to be 61.72%.
Shares Statistics:
For the past three months, SPRO has traded an average of 540.55K shares per day and 532050 over the past ten days. A total of 56.19M shares are outstanding, with a floating share count of 38.59M. Insiders hold about 31.43% of the company’s shares, while institutions hold 14.20% stake in the company. Shares short for SPRO as of 1759190400 were 549473 with a Short Ratio of 1.02, compared to 1756425600 on 503998. Therefore, it implies a Short% of Shares Outstanding of 549473 and a Short% of Float of 1.1900000000000002.
Earnings Estimates
As of right now, 1.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.22, with high estimates of -$0.22 and low estimates of -$0.22.
Analysts are recommending an EPS of between -$0.13 and -$0.79 for the fiscal current year, implying an average EPS of -$0.46. EPS for the following year is -$0.04, with 2.0 analysts recommending between $0.67 and -$0.74.
Revenue Estimates
A total of 1 analysts have provided revenue estimates for SPRO’s current fiscal year. The highest revenue estimate was $20.1M, while the lowest revenue estimate was $20.1M, resulting in an average revenue estimate of $20.1M. In the same quarter a year ago, actual revenue was $47.98MBased on 1 analysts’ estimates, the company’s revenue will be $300k in the next fiscal year. The high estimate is $300k and the low estimate is $300k.
